Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (381-390 of 790) with videos related to

Pageof 79
Sort By:
Psychopharmacology|January 1, 1989
A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremorsG H Bone, E Majchrowicz, P R Martin, et al.
Psychological Medicine|August 1, 1994
Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcomeJ Smith, K Williams, S Birkett, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2021
Cannabis based medicines and cannabis dependence: A critical review of issues and evidenceAnne K Schlag, Chandni Hindocha, Rayyan Zafar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1990
Carbamazepine retards the development of cocaine-kindled seizures but not sensitization to cocaine-induced hyperactivityS R Weiss, R M Post, M Costello, et al.
Elife|October 12, 2020
DMT alters cortical travelling wavesAndrea Alamia, Christopher Timmermann, David J Nutt, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1979
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observationsJ Nutt, A Williams, C Plotkin, et al.
Neuropharmacology|April 1, 1988
Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142H J Little, R Gale, N Sellars, et al.
Annals of the New York Academy of Sciences|March 19, 2004
In vivo estimation of imidazoline(2) binding site turnoverL M Paterson, E S J Robinson, D J Nutt, et al.
Acta Poloniae Pharmaceutica|April 6, 2006
Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-olsAnita Kornicka, Franciszek Saczewski, Robin J Tyacke, et al.
Journal of Psychopharmacology (Oxford, England)|March 15, 2006
A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteersJayne E Bailey, Adrian Kendrick, Alison Diaper, et al.
Pageof 79

Showing results (381-390 of 790) with videos related to

Sort By:
Pageof 79
Psychopharmacology|January 1, 1989
A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremorsG H Bone, E Majchrowicz, P R Martin, et al.
Psychological Medicine|August 1, 1994
Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcomeJ Smith, K Williams, S Birkett, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2021
Cannabis based medicines and cannabis dependence: A critical review of issues and evidenceAnne K Schlag, Chandni Hindocha, Rayyan Zafar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1990
Carbamazepine retards the development of cocaine-kindled seizures but not sensitization to cocaine-induced hyperactivityS R Weiss, R M Post, M Costello, et al.
Elife|October 12, 2020
DMT alters cortical travelling wavesAndrea Alamia, Christopher Timmermann, David J Nutt, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1979
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observationsJ Nutt, A Williams, C Plotkin, et al.
Neuropharmacology|April 1, 1988
Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142H J Little, R Gale, N Sellars, et al.
Annals of the New York Academy of Sciences|March 19, 2004
In vivo estimation of imidazoline(2) binding site turnoverL M Paterson, E S J Robinson, D J Nutt, et al.
Acta Poloniae Pharmaceutica|April 6, 2006
Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-olsAnita Kornicka, Franciszek Saczewski, Robin J Tyacke, et al.
Journal of Psychopharmacology (Oxford, England)|March 15, 2006
A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteersJayne E Bailey, Adrian Kendrick, Alison Diaper, et al.
Pageof 79